Cargando…
Clinical Trial-Ready Patient Cohorts for Multiple System Atrophy: Coupling Biospecimen and iPSC Banking to Longitudinal Deep-Phenotyping
Multiple system atrophy (MSA) is a fatal neurodegenerative disease of unknown etiology characterized by widespread aggregation of the protein alpha-synuclein in neurons and glia. Its orphan status, biological relationship to Parkinson’s disease (PD), and rapid progression have sparked interest in dr...
Ejemplares similares
-
Toward More Accessible Fully Automated 3D Volumetric MRI Decision Trees for the Differential Diagnosis of Multiple System Atrophy, Related Disorders, and Age-Matched Healthy Subjects
por: Kim, Jisoo, et al.
Publicado: (2022) -
Distal urethroplasty for fossa navicularis and meatal strictures
por: Dielubanza, Elodi J., et al.
Publicado: (2014) -
Location of lesion determines motor vs. cognitive consequences in patients with cerebellar stroke
por: Stoodley, Catherine J., et al.
Publicado: (2016) -
Assays for Qualification and Quality Stratification of Clinical Biospecimens Used in Research: A Technical Report from the ISBER Biospecimen Science Working Group
por: Betsou, Fay, et al.
Publicado: (2016) -
Do-it-yourself biospecimens: the benefits of home collection.
por: Barrett, Julia R
Publicado: (2004)